Skip to main content

NASDAQ:GRTS Stock Forecast, Price Targets (Buy or Sell) | GRTS Gritstone Oncology Analyst Ratings



Shared facilities with captive finance entities. When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period.

We estimate GRTS Gritstone Oncology stock forecast parameters by: Simple Moving Average (SMA) with Beta



GRTS Gritstone Oncology Stock Forecast (Buy or Sell) as of 11 May 2022 for (n+1y)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Simple Moving Average (SMA) and Beta. Machine Learning based stock forecast (n+1y) for GRTS Gritstone Oncology as below:

Time series to forecast n: 11 May 2022 for (n+1y)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |